1. Jr. Consultant, Department of Anaesthesiology, DMCH 2. Anaesthesiologist, DMCH 3. Professor & Head, Dept. of Anaesthesiology, DMCH neuropathy, with an annual incidence 1-2 per 100,000 populations 1 . Affecting all ages, 50-60% cases follow viral illness within the preceding months, upto 10% follow vaccination or surgery 1 .
Guillain -Barre Syndrome (GBS) is characterised by sudden onset of skeletal muscle weakness or paralysis typically manifests initially in the legs and spreads cephaled over the ensuing days to involve skeletal muscle of the arms, trunks and face. Bulbar involvement most frequently manifests as bilateral facial paralysis. Difficulty in swallowing due to pharyngeal muscle weakness and impaired ventilation due to intercostal muscle paralysis are the serious serious symptoms 2 . Autonomic nervous system dysfunction is a prominent finding in patient with GBS.
The diagnosis of GBS is based on clinical signs & symptoms 3 , supported by CSF study & a nerve conduction velocity (NCV) test 4 . After the first clinical manifestations of the disease, the symptoms can progress over the course of hours, days or weeks. Most people reach the stage of greatest weakness within the first two weeks after symptoms appear & by the third week of the illness 90% of all patients are at their weakest 4 .
There is no known cure of GBS. However there are therapies that lessen the severity of the illness & accelerate the recovery in most patients. There are also a number of ways to treat the complications of the disease. Currently high dose immunoglobulin & plasma exchange (PE) are used. Since the disease may be complicated by respiratory paralysis and / or severe autonomic instability , it is recognized as a potential neurological emergency that may require intensive care management 5 . Respiratory is the most life threatening complication of GBS & 10 -30% patients may required mechanical ventilation 5, 6 . A higher mortality has been seen in few reports published in India 7, 8 . We review here the morbidity as well as mortality of GBS admitted in intensive care unit (ICU) during the last 5 years between Jan. 2002 to Dec. 2006.
METHODS & MATERIALS:
It was a prospective study of patients of GBS admitted in DMCH who were noted & those were reffered to Intensive care unit (ICU) were managed as per protocol described herein. Diagnosis of GBS was established clinically & supported by data from laboratory whenever available. Age, sex, precipitating events, duration of weakness, baseline symptoms & co-morbid conditions were recorded for all patients. The ultimate outcome measure was hospital survival. Duration of mechanical ventilation & ventilator associated complications (if any) were also recorded.
The patients needed mechanical ventilation were ventilated using Puritan Bennett 7200 AE, T Bird, Bear 3, Bear 33, Servo 900 ventilators. The need of tracheal intubation & mechanical ventilation was determined by serial assessment of respiratory function by clinical examination (level of overall pt. comfort, frequency & depth of breathing, use of accessory muscles, presence of paradoxical respiration, single breath count & integrity of upper airway reflexes), arterial blood gas (ABG) data & chest radiography 9 . Initially, control mode ventilation (CMV) with tidal volumes of around l0ml/ kg was used. Patients were quickly shifted to synchronized intermittent mandatory ventilation (SIMV) with pressure support after stabilization. An effort was made to maintain oxygen fraction in inspired air (Fi02) at <0.5, while maintaining adequate oxygenation (p02 >60 mm Hg). Adequate nutrition, asepsis, humidification of inspired air, and regular endotracheal toileting were ensured.
Chest physiotherapy was applied to prevent atelectasis. Continuous monitoring of hemodynamic & respiratory (including ABG and respiratory mechanics) variables were ensured. Patients were frequently turned in bedd to prevent bed sores. Low dose heparin were administered subcutaneously to decrease risk of venous thrombosis. Immunotherapy with intravenous immunoglobulin (IVIG) was administered wherever feasible, in a dose of 400 mg/ kg daily for 5 days 10 .
Tracheostomy was performed in the second week of ICU stay for patients predicted to require prolonged mechanical ventilation 11 12 which also corresponded with our study. Respiratory complications such as pneumonia and tracheobronchitis occurred in half of the patients and were linked to mechanical ventilation. Systemic infection occurred one fifth of patients and was more frequent with increasing durationa of ICU admission. In our study all patients were managed traditionaly except 7 (seven) patients who received / immunotherapy and no patient treated with plasma exchange(PE). Richard A.C. Hughes, Antony V. Swan, Jean -Claude Raphael et. al. found in one trial with 148 participants following PE with IVIg did not produce significant extra benefit 13 . Limited evidence from three open trials in children suggested that IVIg hastens recovery compared with supportive care alone 13 . Corticosteroids were also compred with placebo or supportive treatment in six trials with altogether 587 patients, inwhich there was significantly less improvement after 4 weeks with corticosteroid than wit out. Two large trial of intravenous methyl-prednisolon with altogether 467 patients found no significant difference between corticosteroid and placebo.
In our study, direct complications of treatment and invasive procedure occurred infrequently. We found that pulmonary morbidity predominates in patients with severe GBS admitted in the ICU. Aggarwal AN, Gupta D, Lal V. et. al. found in their study 10 -30% patient required ventilatory support 14 . in comparison to our study,46% patient needed mechanical ventilation. Complications in critically ill patients with GBS are most often not related to the basic disease. Although autonomic instability can precipitate swings in blood pressure or arrhythmias, these can usually be successfully tackled in well -equipped ICU.
Deaths resulting from GBS are nowadays uncommon, because of advances in all the aspects of intensive care. Mortality rates vary widely, ranging from 1% -18% in most reports from West 15 . Patients requiring mechanical ventilation may have higher mortality rates 3 . Amuch higher mortality rate has been reported from some Indian centers, possibly related to less than ideal intensive care facilities due to financial constraints, like our ICU, when compared to conditions in developed countries 7, 8 . In the modem era, death in GBS usually results from pneumonia, sepsis, adult respiratory syndrome, and less frequently autonomic instability or pulmonary embolism; most of these patients are on ventilatory support 14 . Old age and associated co morbidities increase the risk. Judith M Spies, Kazim A Sheikh found upto 5% of patients did not survive inspite modern intensive care facilities 16 . But in our study mortality rate was 32% of which predominantly aged patient >50 years and patients who developed autonomic involvement. Some patient also expired within 0-1 days without proper diagnosis of GBS, which were may be some other neurological defects like encephalitis, TB meningitis or space occupying lesion (SOL).
CONCLUSION:
In conclusion, ventilatory failure in severe GBS often requires prolonged respiratory support and ICU care. Mechanical ventilation itself is not difficult in these patients with normal lung mechanics and gas exchange. Most patients have a favourable outcome. Mortality is usually related to systemic problems or complications of hospitalization, rather than the basic disease. Further research is needed to identify better treatment regimens and new therapeutic strategies.
